Cargando…
P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431133/ http://dx.doi.org/10.1097/01.HS9.0000970532.16622.f0 |
| _version_ | 1785091128443273216 |
|---|---|
| author | Touzeau, Cyrille Bahlis, Nizar J Maisel, Christopher Karlin, Lionel Nina Varshavsky-Yanovsky, Asya Leip, Eric Conte, Umberto Viqueira, Andrea Larson, Sarah M. |
| author_facet | Touzeau, Cyrille Bahlis, Nizar J Maisel, Christopher Karlin, Lionel Nina Varshavsky-Yanovsky, Asya Leip, Eric Conte, Umberto Viqueira, Andrea Larson, Sarah M. |
| author_sort | Touzeau, Cyrille |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431133 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311332023-08-17 P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3 Touzeau, Cyrille Bahlis, Nizar J Maisel, Christopher Karlin, Lionel Nina Varshavsky-Yanovsky, Asya Leip, Eric Conte, Umberto Viqueira, Andrea Larson, Sarah M. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431133/ http://dx.doi.org/10.1097/01.HS9.0000970532.16622.f0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Touzeau, Cyrille Bahlis, Nizar J Maisel, Christopher Karlin, Lionel Nina Varshavsky-Yanovsky, Asya Leip, Eric Conte, Umberto Viqueira, Andrea Larson, Sarah M. P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title | P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_full | P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_fullStr | P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_full_unstemmed | P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_short | P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_sort | p907: efficacy and safety of elranatamab in high-risk patients with relapsed/refractory multiple myeloma: a subgroup analysis from magnetismm-3 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431133/ http://dx.doi.org/10.1097/01.HS9.0000970532.16622.f0 |
| work_keys_str_mv | AT touzeaucyrille p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 AT bahlisnizarj p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 AT maiselchristopher p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 AT karlinlionel p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 AT ninavarshavskyyanovskyasya p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 AT leiperic p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 AT conteumberto p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 AT viqueiraandrea p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 AT larsonsarahm p907efficacyandsafetyofelranatamabinhighriskpatientswithrelapsedrefractorymultiplemyelomaasubgroupanalysisfrommagnetismm3 |